Ogihara T - Search Results

1

Serum hepatocyte growth factor concentration is correlated with the forearm vasodilator response in hypertensive patients.

Komai N, Ohishi M, Morishita R, Moriguchi A, Kaibe M, Matsumoto K, Rakugi H, Higaki J, Ogihara T. Komai N, et al. Among authors: ogihara t. Am J Hypertens. 2002 Jun;15(6):499-506. doi: 10.1016/s0895-7061(02)02274-4. Am J Hypertens. 2002. PMID: 12074350

2

The renin-angiotensin and adrenergic nervous system in cardiac hypertrophy in fructose-fed rats.

Kamide K, Rakugi H, Higaki J, Okamura A, Nagai M, Moriguchi K, Ohishi M, Satoh N, Tuck ML, Ogihara T. Kamide K, et al. Among authors: ogihara t. Am J Hypertens. 2002 Jan;15(1 Pt 1):66-71. doi: 10.1016/s0895-7061(01)02232-4. Am J Hypertens. 2002. PMID: 11824863

3

Low-dose doxazosin improved aortic stiffness and endothelial dysfunction as measured by noninvasive evaluation.

Komai N, Ohishi M, Moriguchi A, Yanagitani Y, Jinno T, Matsumoto K, Katsuya T, Rakugi H, Higaki J, Ogihara T. Komai N, et al. Among authors: ogihara t. Hypertens Res. 2002 Jan;25(1):5-10. doi: 10.1291/hypres.25.5. Hypertens Res. 2002. PMID: 11924726 Free article. Clinical Trial.

4

Hepatocyte growth factor as cardiovascular hormone: role of HGF in the pathogenesis of cardiovascular disease.

Morishita R, Aoki M, Yo Y, Ogihara T. Morishita R, et al. Among authors: ogihara t. Endocr J. 2002 Jun;49(3):273-84. doi: 10.1507/endocrj.49.273. Endocr J. 2002. PMID: 12201209 Free article. Review.

5

Improvement of endothelial dysfunction by angiotensin II blockade accompanied by induction of vascular hepatocyte growth factor system in diabetic spontaneously hypertensive rats.

Matsumoto K, Morishita R, Tomita N, Moriguchi A, Komai N, Aoki M, Matsumoto K, Nakamura T, Higaki J, Ogihara T. Matsumoto K, et al. Among authors: ogihara t. Heart Vessels. 2003 Mar;18(1):18-25. doi: 10.1007/s003800300003. Heart Vessels. 2003. PMID: 12644877

6

Association of hypoadiponectinemia with impaired vasoreactivity.

Ouchi N, Ohishi M, Kihara S, Funahashi T, Nakamura T, Nagaretani H, Kumada M, Ohashi K, Okamoto Y, Nishizawa H, Kishida K, Maeda N, Nagasawa A, Kobayashi H, Hiraoka H, Komai N, Kaibe M, Rakugi H, Ogihara T, Matsuzawa Y. Ouchi N, et al. Among authors: ogihara t. Hypertension. 2003 Sep;42(3):231-4. doi: 10.1161/01.HYP.0000083488.67550.B8. Epub 2003 Jul 14. Hypertension. 2003. PMID: 12860835

7

Association between hepatocyte growth factor gene polymorphism and essential hypertension.

Motone M, Katsuya T, Ishikawa K, Iwashima Y, Sugimoto K, Yamamoto K, Fu Y, Matsuo A, Ohishi M, Rakugi H, Ogihara T. Motone M, et al. Among authors: ogihara t. Hypertens Res. 2004 Apr;27(4):247-51. doi: 10.1291/hypres.27.247. Hypertens Res. 2004. PMID: 15127882 Free article.

8

Plasma asymmetric dimethylarginine and coronary and peripheral endothelial dysfunction in hypertensive patients.

Takiuchi S, Fujii H, Kamide K, Horio T, Nakatani S, Hiuge A, Rakugi H, Ogihara T, Kawano Y. Takiuchi S, et al. Among authors: ogihara t. Am J Hypertens. 2004 Sep;17(9):802-8. doi: 10.1016/j.amjhyper.2004.05.005. Am J Hypertens. 2004. PMID: 15363823

9

Hepatocyte growth factor as potential cardiovascular therapy.

Nakagami H, Kaneda Y, Ogihara T, Morishita R. Nakagami H, et al. Among authors: ogihara t. Expert Rev Cardiovasc Ther. 2005 May;3(3):513-9. doi: 10.1586/14779072.3.3.513. Expert Rev Cardiovasc Ther. 2005. PMID: 15889978 Review.

10

Serum interleukin-15 concentration in patients with essential hypertension.

Kaibe M, Ohishi M, Ito N, Yuan M, Takagi T, Terai M, Tatara Y, Komai N, Rakugi H, Ogihara T. Kaibe M, et al. Among authors: ogihara t. Am J Hypertens. 2005 Aug;18(8):1019-25. doi: 10.1016/j.amjhyper.2005.02.014. Am J Hypertens. 2005. PMID: 16109314

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,707 results

Search Page